DSM Biologics and Upfront to Develop a Fully Disposable Chromatography System Optimized for High Yield Cell Line Production

Article

DSM Biologics (Heerlen, the Netherlands), and Upfront Chromatography A/S (Copenhagen, Denmark) have announced a collaboration to optimize Upfront’s new, fully disposable chromatography system for use with DSM's proprietary manufacturing technology.

DSM Biologics (Heerlen, the Netherlands), and Upfront Chromatography A/S (Copenhagen, Denmark) have announced a collaboration to optimize Upfront’s new, fully disposable chromatography system for use with DSM's proprietary manufacturing technology. The fully integrated disposable chromatography system is expected to be available for commercial use by the summer of 2008.

The combination of Upfront’s disposable chromatography system and DSM’s proprietary manufacturing technology is designed to deliver a flexible, easy-to-use, high capacity bioprocessing platform that can be scaled from 0.1 to 100 L for commercial manufacture and recovery of a range of biopharmaceuticals, including monoclonal antibodies.

DSM release

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Related Content
© 2025 MJH Life Sciences

All rights reserved.